Atlassian uses cookies to improve your browsing experience, perform analytics and research, and conduct advertising. Accept all cookies to indicate that you agree to our use of cookies on your device. Atlassian cookies and tracking notice, (opens new window)
Welcome to the PHUSE Advance Hub

WORKING GROUPS
Results will update as you type.
  • Working Groups
    • Data Transparency
    • Data Visualisation & Open Source Technology
    • Emerging Trends & Innovation
    • Nonclinical Topics
      • Conformance with the tumor.xpt Specification
      • Developing Predictive Models to Facilitate Interpretation of Toxicology Study Results
      • Nonclinical Study Data Reviewer's Guide
      • SEND Coding Bootcamp
      • SEND Industry Feedback Survey
      • Supporting the Use of SEND for the Implementation of Virtual Control Groups
    • Optimizing the Use of Data Standards
    • pharmaverse
    • Real World Evidence
    • Risk Based Quality Management
    • Safety Analytics
  • Hot Topics
  • Useful Information
  • Deliverables
  • Working Groups Events
  • Working Groups Report – Q3 2025
  • Working Groups Archive
  • Working Groups Events Archive

    You‘re viewing this with anonymous access, so some content might be blocked.
    /
    Nonclinical Study Data Reviewer's Guide

      Nonclinical Study Data Reviewer's Guide

      Oct 01, 2025


      Project Scope

      This project is to evolve the Nonclinical Study Data Reviewer's Guide (nSDRG), based on comments from a public PHUSE review, plus to adapt it to updates of the FDA Technical Conformance Guide. The project continues to check and align with the SDRG template and guide developed by the Optimizing the Use of Data Standards Working Group for clinical studies.

      Preparation of a Study Data Reviewer’s Guide (SDRG) is recommended as an integral part of a CDISC standards-compliant study data submission. The challenge is to operationalise this new documentation requirement efficiently and effectively.

      Challenges we seek to answer with this project:

      • Provide a practical template for easy access and use

      • Provide guidance document which describes expected content and options to guide nonclinical SDRG authors.

      • Provide authors with examples, describing how to handle different data situations with SDRG content.

      Things we expect to learn along the way:

      • Exploration of ways to generate the nonclinical SDRG and who should do the job.

      • The SDRG is expected to be useful by FDA reviewers. Can it also be useful for other nonclinical study stakeholders?

      • Will the SDRG evolve as systems and processes gain expertise in the new SEND requirements for submission of nonclinical data?

      Project Leads

      Email

      Janessa Pierce, Merck

      janessa_pierce@merck.com

      Sue DeHaven, Sanofi

      susan.dehaven@sanofi.com

      Alex Pearce, PHUSE Project Assistant

      Alexandra@phuse.global

      CURRENT STATUS (Updated Quarterly) 

      • ​No update provided this quarter


      Published Deliverables

      nSDRG v1.2 

      Version 1.2, 8 April 2022
      Maintaining the Clinical & Nonclinical Study Data Reviewers Guides CSS 2018 Workshop

      Nonclinical SDRG Package

      The Nonclinical SDRG package has been developed to comply with the FDA's Study Data Technical Conformance Guide. The current version of this document can be found at the website: FDA Data Standards Resources. The nSDRG team continues to monitor FDA's Technical Conformance Guide updates (which occur 2X per year, expected in MAR and OCT) and also public comments received from users of nSDRG. As these new inputs are evaluated, we will post answers in the SEND Implementation Forum, and update the published documents as needed. Stay tuned for update announcements.

      , multiple selections available,
      {"serverDuration": 10, "requestCorrelationId": "e0035c5eee3f41499ec5a79fe28896d7"}